ABL Bio Inc. (298380.KQ) KOE
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 10.77T |
| Enterprise Value | 10.71T |
| P/E Ratio | -52.11 |
| PEG Ratio | 0.2 |
| Price/Sales Ratio | 122.81 |
| Price/Book Ratio | 24.55 |
| Enterprise/Revenue | 119.61 |
| Enterprise/EBITDA | -50.8 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -2.29 |
| Operating Margin | -2.51 |
AD
Management Effectiveness
| Return On Assets | -0.29 |
| Return On Equity | -0.46 |
Income Statement
| Revenue | 79.35B |
| Revenue/Share | 612.34 |
| Gross Profit | 45.85B |
| EBITDA | -36.94B |
| Net Income | -37.88B |
| Diluted EPS | -703.38 |
Balance Sheet
| Total Cash | 167.08B |
| Total Cash/Share | 2,984.33 |
| Total Debt | 55.45B |
| Total Debt/Equity | 0.32 |
| Current Ratio | 1.72 |
| Book Value Per Share | 3,106.81 |
Price History
| 52-Week Change | -15.32 |
| 52-Week High | 257,500 |
| 52-Week Low | 59,800 |
| Moving Average 50 Days | 84,876 |
| Moving Average 200 Days | 147,733.5 |
Statistics
| Average Volume | 399,487 |
| Shares Outstanding | 55.99M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
